Influence of Probiotics Administration on Gut Microbiota Core A Review on the Effects on Appetite Control, Glucose, and Lipid Metabolism

Journal of Clinical Gastroenterology

Volumn 52, Issue , 2018, Pages S50-S56

  Falcinelli, Silvia ^a   Rodiles, Ana ^b   Hatef, Azadeh ^c   Picchietti, Simona ^d   Cossignani, Lina ^e   Merrifield, Daniel L ^b   Unniappan, Suraj ^c   Carnevali, Oliana ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF TUSCIA   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

Author keywords

appetite control; glucose metabolism; gut metabolites; gut microbiota; lipid metabolism; probiotics

Indexed keywords

GLUCOSE; LIPID; PROBIOTIC AGENT;

APPETITE; ARTICLE; COLONY FORMING UNIT; DIET INDUCED OBESITY; ENERGY METABOLISM; GLUCOSE METABOLISM; HUMAN; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS GASSERI; LACTOCOCCUS; LEUCONOSTOC; LIPID METABOLISM; NONHUMAN; PEDIOCOCCUS; PRIORITY JOURNAL; STREPTOCOCCUS; ANIMAL; FOOD INTAKE; GLUCOSE BLOOD LEVEL; METABOLISM; PHYSIOLOGY;

ANIMALS; APPETITE REGULATION; BLOOD GLUCOSE; ENERGY METABOLISM; GASTROINTESTINAL MICROBIOME; HUMANS; LIPID METABOLISM; PROBIOTICS;

EID: 85048258604     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000001064     Document Type: Article

References (95)

1. Granato D, Branco GF, Nazzaro F, et al. Functional foods and nondairy probiotic food development: trends, concepts, and products. Compr Rev Food Sci Food Saf. 2010;9:292-302.
2. Olivares M, Díaz-Ropero MP, Gómez N, et al. The consumption of two new probiotic strains, Lactobacillus gasseri CECT 5714 and Lactobacillus coryniformis CECT 5711, boosts the immune system of healthy humans. Int Microbiol. 2006;9:47-52.
3. Kechagia M, Basoulis D, Konstantopoulou S, et al. Health benefits of probiotics: a review. ISRN Nutr. 2013;2013:481651.
4. Bagarolli RA, Tobar N, Oliveira AG, et al. Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice. J Nutr Biochem. 2017;50:16-25.
5. Wang J, Tang H, Zhang C, et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J. 2015;9:1-15.
6. Rao RK, Samak G. Protection and restitution of gut barrier by probiotics: nutritional and clinical implications. Curr Nutr Food Sci. 2013;9:99-107.
7. Hsieh C-Y, Osaka T, Moriyama E, et al. Strengthening of the intestinal epithelial tight junction by Bifidobacterium bifidum. Physiol Rep. 2015;3:3.
8. Falcinelli S, Picchietti S, Rodiles A, et al. Lactobacillus rhamnosus lowers zebrafish lipid content by changing gut microbiota and host transcription of genes involved in lipid metabolism. Sci Rep. 2015;5:9336.
9. Ghosh S, van Heel D, Playford RJ. Probiotics in inflammatory bowel disease: is it all gut flora modulation? Gut. 2004;53:620-622.
10. Quigley EMM. Gut bacteria in health and disease. Gastroenterol Hepatol. 2013;9:560-569.
11. Isolauri E, Kirjavainen PV, Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut. 2002; 50(suppl 3):III54-III59.
12. Parvaneh K, Jamaluddin R, Karimi G, et al. Effect of probiotics supplementation on bone mineral content and bone mass density. Sci World J. 2014;2014:595962.
13. Maradonna F, Gioacchini G, Falcinelli S, et al. Probiotic supplementation promotes calcification in Danio rerio larvae: a molecular study. PloS one. 2013;8:e83155.
14. Ashraf R, Shah NP. Immune system stimulation by probiotic microorganisms. Crit Rev Food Sci Nutr. 2014;54:938-956.
15. Gioacchini G, Giorgini E, Olivotto I, et al. The influence of probiotics on zebrafish Danio rerio innate immunity and hepatic stress. Zebrafish. 2014;11:98-106.
16. Pekmez CT, Dragsted LO, Brahe LK. Gut microbiota alterations and dietary modulation in childhood malnutrition-the role of short chain fatty acids. Clin Nutr. 2018. [Epub February 17, 2018].
17. Donohoe DR, Garge N, Zhang X, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011;13:517-526.
18. Saulnier DM, Santos F, Roos S, et al. Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features. PLoS ONE. 2011;6:e18783.
19. Kuratsu M, Hamano Y, Dairi T. Analysis of the Lactobacillus metabolic pathway. Appl Environ Microbiol. 2010;76:7299-7301.
20. Santer M. Joseph Lister: first use of a bacterium as a "model organism" to illustrate the cause of infectious disease of humans. Notes Rec R Soc. 2010;64:59-65.
21. Claesson MJ, van Sinderen D, O'Toole PW. The genus Lactobacillus a genomic basis for understanding its diversity. FEMS Microbiol Lett. 2007;269:22-28.
22. Cani PD, Lecourt E, Dewulf EM, et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr. 2009;90:1236-1243.
23. Franzosa EA, Huang K, Meadow JF, et al. Identifying personal microbiomes using metagenomic codes. Proc Natl Acad Sci. 2015;112:E2930-E2938.
24. Peterson CT, Sharma V, Elmén L, et al. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin Exp Immunol. 2015;179:363-377.
25. Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16:341-352.
26. Rowland I, Gibson G, Heinken A, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018;57:1-24.
27. Hemarajata P, Versalovic J. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Ther Adv Gastroenterol. 2012;6:39-51.
28. Vernocchi P, Del Chierico F, Putignani L. Gut microbiota profiling: metabolomics based approach to unravel compounds affecting human health. Front Microbiol. 2016;7:1144.
29. Del Chierico F, Vernocchi P, Bonizzi L, et al. Early-life gut microbiota under physiological and pathological conditions: the central role of combined meta-omics-based approaches. J Proteomics. 2012;75:4580-4587.
30. Zhang Y, Zhang H. The effect of probiotics on lipid metabolism. in: lipid metabolism. In: Baez RV, ed. InTech. 2013. Available at: http://www. intechopen. com/embed/lipid-metabolism/the-effectof-probiotics-on-lipid-metabolism. Accessed January 23, 2013.
31. Cho YA, Kim J. Effect of probiotics on blood lipid concentrations. Medicine. 2015;94:e1714.
32. Kim YA, Keogh JB, Clifton PM. Probiotics, prebiotics, synbiotics and insulin sensitivity. Nutr Res Rev. 2017;17:1-17.
33. Foster JA. Gut feelings: bacteria and the brain. Cerebrum. 2013; 2013:9.
34. Powell N, Walker MM, Talley NJ. The mucosal immune system: master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol. 2017;14:143-159.
35. Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol. 2009;6:306-314.
36. Foster JA, Rinaman L, Cryan JF. Stress & the gut-brain axis: regulation by the microbiome. Neurobiol Stress. 2017;7:124-136.
37. Kennedy PJ, Murphy AB, Cryan JF, et al. Microbiome in brain function and mental health. Trends Food Sci Technol. 2016; 57:289-301.
38. Burokas A, Moloney RD, Dinan TG, et al. Microbiota regulation of the mammalian gut-brain axis. Adv Appl Microbiol. 2015;91:1-62.
39. Moroti C, Souza Magri L, de Rezende Costa M, et al. Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis. 2012;11:29.
40. Andreasen AS, Larsen N, Pedersen-Skovsgaard T, et al. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr. 2010;104:1831-1838.
41. O'Shea EF, Cotter PD, Stanton C, et al. Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid. Int J Food Microbiol. 2012;152:189-205.
42. Zartl B, Silberbauer K, Loeppert R, et al. Fermentation of nondigestible raffinose family oligosaccharides and galactomannans by probiotics. Food Funct. 2018;9:1638-1646.
43. Byrne CS, Chambers ES, Morrison DJ, et al. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int J Obes. 2015;39:1331-1338.
44. Taylor GR, Williams CM. Effects of probiotics and prebiotics on blood lipids. Br J Nutr. 1998;80:S225-S230.
45. Kumar M, Nagpal R, Kumar R, et al. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res. 2012;2012:902917.
46. Chiang Y-R, Ismail W, Heintz D, et al. Study of anoxic and oxic cholesterol metabolism by Sterolibacterium denitrificans. J Bacteriol. 2008;190:905-914.
47. Anderson RC, Cookson AL, McNabb WC, et al. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol. 2010;10:316.
48. Martin F-PJ, Sprenger N, Montoliu I, et al. Dietary modulation of gut functional ecology studied by fecal metabonomics. J Proteome Res. 2010;9:5284-5295.
49. Nishiyama K, Sugiyama M, Mukai T. Adhesion properties of lactic acid bacteria on intestinal mucin. Microorganisms. 2016;4:3.
50. Collado MC, Gueimonde M, Hernández M, et al. Adhesion of selected Bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion. J Food Prot. 2005;68:2672-2678.
51. González-Rodríguez I, Sánchez B, Ruiz L, et al. Role of extracellular transaldolase from Bifidobacterium bifidum in mucin adhesion and aggregation. Appl Environ Microbiol. 2012; 78:3992-3998.
52. Dahiya DK, Renuka, Puniya M, et al. Gut microbiota modulation and its relationship with obesity using prebiotic fibers and probiotics: a review. Front Microbiol. 2017;8:563.
53. Semova I, Carten JD, Stombaugh J, et al. Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish. Cell Host Microbe. 2012;12:277-288.
54. Kalliomäki M, Salminen S, Isolauri E. Positive interactions with the microbiota: probiotics. In: Huffnagle GB, Noverr MC, eds. GI Microbiota and Regulation of the Immune System Vol. 635. New York, NY: Springer; 2008:57-66.
55. Taranto MP, Medici M, Perdigon G, et al. Effect of Lactobacillus reuteri on the prevention of hypercholesterolemia in mice. J Dairy Sci. 2000;83:401-403.
56. El-Shafie H, Yahia N, Ali H. Hypocholesterolemic action of Lactobacillus plantarum NRRL-B-4524 and Lactobacillus paracasei in mice with hypercholesterolemia induced by diet. Australian J Basic Appl Sci. 2009;3:218-228.
57. Falcinelli S, Rodiles A, Hatef A, et al. Dietary lipid content reorganizes gut microbiota and probiotic L. rhamnosus attenuates obesity and enhances catabolic hormonal milieu in zebrafish. Sci Rep. 2017;7:1-15.
58. Kang D, Li Z, Ji GE. Anti-obese effects of a mixture of fermented Ginseng, Bifidobacterium longum BORI, and Lactobacillus paracasei CH88 in high-fat diet-fed mice. J Microbiol Biotechnol. 2018. In Press.
59. Hlivak P, Odraska J, Ferencik M, et al. One-year application of probiotic strain Enterococcus faecium M-74 decreases serum cholesterol levels. Bratislavske lekarske listy. 2005;106: 67-72.
60. Kobyliak N, Abenavoli L, Mykhalchyshyn G, et al. A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial. J Gastrointestin Liver Dis. 2018;27:41-49.
61. Simons LA, Amansec SG, Conway P. Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutr Metab Cardiovasc Dis. 2006;16:531-535.
62. Hatakka K, Mutanen M, Holma R, et al. Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp shermanii JS administered in capsules is ineffective in lowering serum lipids. J Am Coll Nutr. 2008;27:441-447.
63. Polakof S, Panserat S, Soengas JL, et al. Glucose metabolism in fish: a review. J Comp Physiol B. 2012;182:1015-1045.
64. Gancheva S, Roden M. Central regulation of glucose metabolism in humans: fact or fiction? Diabetes. 2016;65:2467-2469.
65. Moosheer SM, Waldschütz W, Itariu BK, et al. A proteinenriched low glycemic index diet with omega-3 polyunsaturated fatty acid supplementation exerts beneficial effects on metabolic control in type 2 diabetes. Prim Care Diabetes. 2014;8:308-314.
66. Gao D, Ning N, Wang C, et al. Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis. PLoS ONE. 2013;8:e73965.
67. Ding M, Bhupathiraju SN, Chen M, et al. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care. 2014;37:569-586.
68. Tabuchi M, Ozaki M, Tamura A, et al. Antidiabetic effect of Lactobacillus GG in Streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem. 2003;67:1421-1424.
69. Panwar H, RashmiHM, Batish VK, et al. Probiotics as potential biotherapeutics in the management of type 2 diabetes-prospects and perspectives. Diab Metab Res Rev. 2013;29:103-112.
70. Falcinelli S, Rodiles A, Unniappan S, et al. Probiotic treatment reduces appetite and glucose level in the zebrafish model. Sci Rep. 2016;6:18061.
71. Bauer PV, Duca FA, Waise TMZ, et al. Lactobacillus gasseri in the upper small intestine impacts an ACSL3-dependent fatty acid-sensing pathway regulating whole-body glucose homeostasis. Cell Metab. 2018;27:572. e6-587. e6.
72. Tonucci LB, Olbrich dos Santos KM, Licursi de Oliveira L, et al. Clinical application of probiotics in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study. Clin Nutr. 2017;36:85-92.
73. Ivey KL, Hodgson JM, Kerr DA, et al. The effects of probiotic bacteria on glycaemic control in overweight men and women: a randomised controlled trial. Eur J Clin Nutr. 2014;68:447-452.
74. Larsen N, Vogensen FK, van den Berg FWJ, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE. 2010;5:e9085.
75. Volkoff H. The neuroendocrine regulation of food intake in fish: a review of current knowledge. Front Neurosci. 2016;10:540.
76. Hopkins M, Blundell JE. Energy Metabolism and Appetite Control: Separate Roles for Fat-Free Mass and Fat Mass in the Control of Food Intake in Humans Appetite and Food Intake: Central Control, Chapter 12. Boca Raton; FL: CRC Press/ Taylor & Francis; 2017.
77. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev. 2007;8:21-34.
78. Clément K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998;392:398-401.
79. Zhou Y, Rui L. Leptin signaling and leptin resistance. Front Med. 2013;7:207-222.
80. Di Marzo V, Goparaju SK, Wang L, et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature. 2001;410:822-825.
81. Di Marzo V, Matias I. Endocannabinoid control of food intake and energy balance. Nat Neurosci. 2005;8:585-589.
82. Muraoka O, Xu B, Tsurumaki T, et al. Leptin-induced transactivation of NPY gene promoter mediated by JAK1, JAK2 and STAT3 in the neural cell lines. Neurochem Int. 2003;42:591-601.
83. Nogueiras R, Wiedmer P, Perez-Tilve D, et al. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest. 2007;117:3475-3488.
84. Balthasar N, Dalgaard LT, Lee CE, et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell. 2005;123:493-505.
85. Yokobori E, Azuma M, Nishiguchi R, et al. Neuropeptide Y stimulates food intake in the zebrafish, Danio rerio. J Neuroendocrinol. 2012;24:766-773.
86. Di Marzo V, Melck D, Bisogno T, et al. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 1998;21:521-528.
87. Pai W-Y, Hsu C-C, Lai C-Y, et al. Cannabinoid receptor 1 promotes hepatic lipid accumulation and lipotoxicity through the induction of SREBP-1c expression in zebrafish. Trans Res. 2013;22:823-838.
88. van de Wouw M, Schellekens H, Dinan TG, et al. Microbiotagut-brain axis: modulator of host metabolism and appetite. J Nutr. 2017;147:727-745.
89. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13:701-712.
90. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. 2012; 10:735-742.
91. Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334:105-108.
92. Fava F, Gitau R, Griffin BA, et al. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and shortchain fatty acid excretion in a metabolic syndrome "at-risk" population. Int J Obes. 2013;37:216-223.
93. Bjerg AT, Kristensen M, Ritz C, et al. Lactobacillus paracasei subsp paracasei L. casei W8 suppresses energy intake acutely. Appetite. 2014;82:111-118.
94. Bondue P, Delcenserie V. Genome of Bifidobacteria and carbohydrate metabolism. Korean J Food Sci Anim Resour. 2015; 35:1-9.
95. Sanchez M, Darimont C, Panahi S, et al. Effects of a diet-based weight-reducing program with probiotic supplementation on satiety efficiency, eating behaviour traits, and psychosocial behaviours in obese individuals. Nutrients. 2017;9:3.